Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy.

<h4>Introduction</h4>The Residual Cancer Burden (RCB) quantifies residual disease after neoadjuvant chemotherapy (NAC). Its predictive value has not been validated on large cohorts with long-term follow up. The objective of this work is to independently evaluate the prognostic value of the RCB index...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Anne-Sophie Hamy, Lauren Darrigues, Enora Laas, Diane De Croze, Lucian Topciu, Giang-Thanh Lam, Clemence Evrevin, Sonia Rozette, Lucie Laot, Florence Lerebours, Jean-Yves Pierga, Marie Osdoit, Matthieu Faron, Jean-Guillaume Feron, Marick Laé, Fabien Reyal
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2020-01-01
coleção:	PLoS ONE
Acesso em linha:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0234191&type=printable
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!